





Acta Cryst. (2003). B59, 787-793 [ doi:10.1107/S0108768103022729 ]
Abstract: The three-dimensional solid-state structures of two modifications of doxazosin mesylate C23H26N5O5+·CH3SO3-, 4-amino-2-[4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazin-1-yl]-6,7-dimethoxyquinazoline methanesulfonate, a commonly used antihypertensive agent, have been determined by synchrotron X-ray powder diffraction. An anhydrous form (A) and a dihydrate form (dG) crystallize in monoclinic space groups. In both forms the doxazosin molecule is protonated at the N1 atom of the quinazoline bicycle. The N1 atom, and the amino H atoms and O atoms of the mesylate moieties are involved in three-dimensional hydrogen-bonding networks, while solvent water molecules and carboxamide O atoms are also incorporated in a hydrogen-bonding network in dG.
Keywords: doxazosin mesylate; polymorphism; synchrotron powder diffraction; structure determination from powder data; grid search; Rietveld refinement.
![]() ![]() Rietveld powder data file (CIF format) (229.6 kbytes) | |
![]() ![]() Rietveld powder data file (CIF format) (330.5 kbytes) | |
To open or display or play some files, you may need to set your browser up to use the appropriate software. See the full list of file types for an explanation of the different file types and their related mime types and, where available links to sites from where the appropriate software may be obtained.
The download button will force most browsers to prompt for a file name to store the data on your hard disk.
Where possible, images are represented by thumbnails.
Copyright © International Union of Crystallography
IUCr Webmaster